➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Dow
Johnson and Johnson
Mallinckrodt
Moodys

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

ROMIDEPSIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Romidepsin patents expire, and when can generic versions of Romidepsin launch?

Romidepsin is a drug marketed by Teva Pharms Usa Inc and is included in one NDA.

The generic ingredient in ROMIDEPSIN is romidepsin. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the romidepsin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Romidepsin

A generic version of ROMIDEPSIN was approved as romidepsin by TEVA PHARMS USA INC on March 13th, 2020.

  Try it Free

Paragraph IV (Patent) Challenges for ROMIDEPSIN
Tradename Dosage Ingredient NDA Submissiondate
ISTODAX POWDER;INTRAVENOUS romidepsin 022393 2013-11-05

US Patents and Regulatory Information for ROMIDEPSIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa Inc ROMIDEPSIN romidepsin SOLUTION;INTRAVENOUS 208574-001 Mar 13, 2020 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva Pharms Usa Inc ROMIDEPSIN romidepsin SOLUTION;INTRAVENOUS 208574-002 Mar 13, 2020 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Dow
Johnson and Johnson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.